Coexpression cluster:C537
From FANTOM5_SSTAR
Full id: C537_immature_CD14_migratory_Mast_CD4_Dendritic_Basophils
Phase1 CAGE Peaks
Hg19::chr12:100967533..100967548,+ | p3@GAS2L3 |
Hg19::chr13:99948360..99948387,- | p5@GPR183 |
Hg19::chr13:99959641..99959660,- | p1@GPR183 |
Hg19::chr16:11670817..11670855,- | p@chr16:11670817..11670855 - |
Hg19::chr18:56338201..56338239,+ | p8@MALT1 |
Hg19::chr18:56338750..56338823,+ | p2@MALT1 |
Hg19::chr1:192544895..192544912,+ | p1@RGS1 |
Hg19::chr1:192545731..192545733,+ | p@chr1:192545731..192545733 + |
Hg19::chr1:192548520..192548535,+ | p@chr1:192548520..192548535 + |
Hg19::chr1:192548540..192548575,+ | p@chr1:192548540..192548575 + |
Hg19::chr1:192578548..192578577,+ | p@chr1:192578548..192578577 + |
Hg19::chr1:206756466..206756481,+ | p15@RASSF5 |
Hg19::chr1:206756498..206756508,+ | p13@RASSF5 |
Hg19::chr2:201997492..201997510,+ | p22@CFLAR |
Hg19::chr6:134495992..134496010,- | p1@SGK1 |
Hg19::chr7:6066589..6066602,- | p4@EIF2AK1 |
Hg19::chr9:134505871..134505884,- | p@chr9:134505871..134505884 - |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0048523 | negative regulation of cellular process | 2.24315862494925e-07 |
GO:0048519 | negative regulation of biological process | 2.24315862494925e-07 |
GO:0050794 | regulation of cellular process | 0.0017810822156576 |
GO:0030693 | caspase activity | 0.0017810822156576 |
GO:0050789 | regulation of biological process | 0.0017810822156576 |
GO:0065007 | biological regulation | 0.00257669638261057 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 0.00376780878370422 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 0.00376780878370422 |
GO:0007242 | intracellular signaling cascade | 0.00376780878370422 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 0.00376780878370422 |
GO:0046986 | negative regulation of hemoglobin biosynthetic process | 0.00376780878370422 |
GO:0045993 | negative regulation of translational initiation by iron | 0.00376780878370422 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 0.0042882600480954 |
GO:0009966 | regulation of signal transduction | 0.0042882600480954 |
GO:0004197 | cysteine-type endopeptidase activity | 0.0042882600480954 |
GO:0009967 | positive regulation of signal transduction | 0.0042882600480954 |
GO:0006915 | apoptosis | 0.0042882600480954 |
GO:0012501 | programmed cell death | 0.0042882600480954 |
GO:0006447 | regulation of translational initiation by iron | 0.0042882600480954 |
GO:0016265 | death | 0.0042882600480954 |
GO:0008219 | cell death | 0.0042882600480954 |
GO:0006916 | anti-apoptosis | 0.0042882600480954 |
GO:0032449 | CBM complex | 0.00583273858869478 |
GO:0045786 | negative regulation of progression through cell cycle | 0.00583273858869478 |
GO:0043066 | negative regulation of apoptosis | 0.00583273858869478 |
GO:0043069 | negative regulation of programmed cell death | 0.00583273858869478 |
GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity | 0.00583273858869478 |
GO:0042541 | hemoglobin biosynthetic process | 0.00583273858869478 |
GO:0002711 | positive regulation of T cell mediated immunity | 0.00583273858869478 |
GO:0002726 | positive regulation of T cell cytokine production | 0.00583273858869478 |
GO:0032743 | positive regulation of interleukin-2 production | 0.00583273858869478 |
GO:0002369 | T cell cytokine production | 0.00656329538340829 |
GO:0020027 | hemoglobin metabolic process | 0.00656329538340829 |
GO:0002724 | regulation of T cell cytokine production | 0.00656329538340829 |
GO:0048468 | cell development | 0.00656329538340829 |
GO:0002720 | positive regulation of cytokine production during immune response | 0.00695339556003099 |
GO:0002709 | regulation of T cell mediated immunity | 0.00695339556003099 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 0.00695339556003099 |
GO:0032663 | regulation of interleukin-2 production | 0.00695339556003099 |
GO:0008234 | cysteine-type peptidase activity | 0.00724077483814711 |
GO:0000074 | regulation of progression through cell cycle | 0.00859537530791841 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.00859537530791841 |
GO:0002718 | regulation of cytokine production during immune response | 0.00859537530791841 |
GO:0002700 | regulation of production of molecular mediator of immune response | 0.00859537530791841 |
GO:0002821 | positive regulation of adaptive immune response | 0.00859537530791841 |
GO:0002367 | cytokine production during immune response | 0.00859537530791841 |
GO:0045947 | negative regulation of translational initiation | 0.00859537530791841 |
GO:0051726 | regulation of cell cycle | 0.00859537530791841 |
GO:0043621 | protein self-association | 0.00859537530791841 |
GO:0002705 | positive regulation of leukocyte mediated immunity | 0.00859537530791841 |
GO:0002456 | T cell mediated immunity | 0.00859537530791841 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 0.00859537530791841 |
GO:0007243 | protein kinase cascade | 0.00859537530791841 |
GO:0002699 | positive regulation of immune effector process | 0.00920342365642115 |
GO:0007250 | activation of NF-kappaB-inducing kinase | 0.0095109723453188 |
GO:0002703 | regulation of leukocyte mediated immunity | 0.0095109723453188 |
GO:0002706 | regulation of lymphocyte mediated immunity | 0.0095109723453188 |
GO:0002819 | regulation of adaptive immune response | 0.00995354786076241 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. | 0.00995354786076241 |
GO:0008047 | enzyme activator activity | 0.0108648337132161 |
GO:0002697 | regulation of immune effector process | 0.0108648337132161 |
GO:0048869 | cellular developmental process | 0.0108648337132161 |
GO:0030154 | cell differentiation | 0.0108648337132161 |
GO:0050852 | T cell receptor signaling pathway | 0.0119957574765944 |
GO:0007193 | G-protein signaling, adenylate cyclase inhibiting pathway | 0.012315593328365 |
GO:0019209 | kinase activator activity | 0.012315593328365 |
GO:0032623 | interleukin-2 production | 0.0141506172788111 |
GO:0042981 | regulation of apoptosis | 0.015046854486826 |
GO:0001819 | positive regulation of cytokine production | 0.015046854486826 |
GO:0043067 | regulation of programmed cell death | 0.0150471991741007 |
GO:0002440 | production of molecular mediator of immune response | 0.0169227294353164 |
GO:0050851 | antigen receptor-mediated signaling pathway | 0.0169227294353164 |
GO:0022402 | cell cycle process | 0.0169247527158631 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 0.0182908043949664 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 0.0186471190494062 |
GO:0002757 | immune response-activating signal transduction | 0.0189939697488288 |
GO:0002764 | immune response-regulating signal transduction | 0.019331725228904 |
GO:0008624 | induction of apoptosis by extracellular signals | 0.0195617293708246 |
GO:0007165 | signal transduction | 0.0195617293708246 |
GO:0005515 | protein binding | 0.0195617293708246 |
GO:0065003 | macromolecular complex assembly | 0.0220037306241794 |
GO:0017148 | negative regulation of translation | 0.0220037306241794 |
GO:0050870 | positive regulation of T cell activation | 0.0220037306241794 |
GO:0001817 | regulation of cytokine production | 0.0220037306241794 |
GO:0046777 | protein amino acid autophosphorylation | 0.0228721929696117 |
GO:0051168 | nuclear export | 0.0228721929696117 |
GO:0004175 | endopeptidase activity | 0.0228721929696117 |
GO:0031327 | negative regulation of cellular biosynthetic process | 0.0228721929696117 |
GO:0022607 | cellular component assembly | 0.0228721929696117 |
GO:0016540 | protein autoprocessing | 0.0228721929696117 |
GO:0007154 | cell communication | 0.0228721929696117 |
GO:0007049 | cell cycle | 0.0238033305506717 |
GO:0051251 | positive regulation of lymphocyte activation | 0.0244407496816509 |
GO:0009890 | negative regulation of biosynthetic process | 0.0244407496816509 |
GO:0006446 | regulation of translational initiation | 0.0265446408743006 |
GO:0019992 | diacylglycerol binding | 0.0273839977685522 |
GO:0050863 | regulation of T cell activation | 0.0273839977685522 |
GO:0051259 | protein oligomerization | 0.0283440663215144 |
GO:0048522 | positive regulation of cellular process | 0.0283440663215144 |
GO:0032147 | activation of protein kinase activity | 0.031489309870482 |
GO:0002253 | activation of immune response | 0.0316206014706882 |
GO:0002449 | lymphocyte mediated immunity | 0.0317492540192714 |
GO:0002250 | adaptive immune response | 0.0325284149901371 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0325284149901371 |
GO:0051249 | regulation of lymphocyte activation | 0.0325284149901371 |
GO:0048518 | positive regulation of biological process | 0.0325284149901371 |
GO:0002443 | leukocyte mediated immunity | 0.0327733114089864 |
GO:0050865 | regulation of cell activation | 0.0332975156710067 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 0.0345909721499402 |
GO:0050778 | positive regulation of immune response | 0.0345909721499402 |
GO:0002684 | positive regulation of immune system process | 0.0345909721499402 |
GO:0032502 | developmental process | 0.0345909721499402 |
GO:0019933 | cAMP-mediated signaling | 0.0345909721499402 |
GO:0006955 | immune response | 0.0375347261122997 |
GO:0042110 | T cell activation | 0.0376609939647763 |
GO:0050776 | regulation of immune response | 0.0376609939647763 |
GO:0006413 | translational initiation | 0.0376609939647763 |
GO:0016485 | protein processing | 0.0376609939647763 |
GO:0002682 | regulation of immune system process | 0.0377189576754196 |
GO:0007050 | cell cycle arrest | 0.0377759005116457 |
GO:0008233 | peptidase activity | 0.0379408528307297 |
GO:0051248 | negative regulation of protein metabolic process | 0.0379408528307297 |
GO:0009968 | negative regulation of signal transduction | 0.0379408528307297 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0379939572091468 |
GO:0002252 | immune effector process | 0.0394702486707968 |
GO:0001816 | cytokine production | 0.0402160355131639 |
GO:0004871 | signal transducer activity | 0.0402866767778344 |
GO:0060089 | molecular transducer activity | 0.0402866767778344 |
GO:0006508 | proteolysis | 0.0402866767778344 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 0.0403465209399871 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 0.0414180612908684 |
GO:0019207 | kinase regulator activity | 0.0414180612908684 |
GO:0002376 | immune system process | 0.0430407520909788 |
GO:0022618 | protein-RNA complex assembly | 0.046395642167172 |
GO:0045860 | positive regulation of protein kinase activity | 0.046395642167172 |
GO:0005516 | calmodulin binding | 0.046395642167172 |
GO:0033674 | positive regulation of kinase activity | 0.0470265471912302 |
GO:0051347 | positive regulation of transferase activity | 0.0476478819210036 |
GO:0006913 | nucleocytoplasmic transport | 0.0494565020587583 |
GO:0046649 | lymphocyte activation | 0.0494565020587583 |
GO:0051169 | nuclear transport | 0.0494565020587583 |
GO:0042803 | protein homodimerization activity | 0.0497304947002505 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.